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WT1 regulates the expression of the major glomerular podocyte
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The WT1 tumor suppressor gene encodes a zinc Results and discussion
To establish an appropriate cell type in which to identifyfinger transcription factor expressed in
differentiating glomerular podocytes. Complete physiological targets genes of WT1, we made use of
RSTEM cells, rat embryonic kidney cells dissected frominactivation of WT1 in the mouse leads to failure
of mesenchymal induction and renal agenesis, an the undifferentiated renal mesenchyme at embryonic day
12.5, preceding invasion by the ureteric bud and inductionearly developmental phenotype that prevents
analysis of subsequent stages in glomerular of differentiation [5]. These cells were reversibly trans-
formed using temperature-sensitive SV40 largeT antigen,differentiation [1]. In humans with Denys-Drash
Syndrome, a heterozygous germline mutation in allowing long-term in vitro culture at the permissive tem-
perature (32C). Inactivation of T antigen by a tempera-WT1 is associated with specific defects in
glomeruli and an increased risk for developing ture shift to 39C restores their differentiation potential,
demonstrated by their ability to contribute to the forma-Wilms Tumor [2, 3]. WT1 target genes implicated
in cell cycle regulation and cellular proliferation have tion of mature kidney structures after reinoculation into
12.5-day kidney rudiments [5]. Consistent with theirbeen proposed [4], but the link between WT1
function and glomerular differentiation is metanephric mesenchymal origin, RSTEM cells express
endogenous WT1 when cultured at 32C, with a progres-unexplained. Here, we show that inducible
expression of WT1 in rat embryonic kidney cell sive reduction in expression following a temperature shift
to 39C (Figure 1a).precursors leads to the induction of endogenous
Podocalyxin, the major structural membrane protein
of glomerular podocytes, which is implicated in the We generated multiple independent RSTEM cell lines
maintenance of filtration slits. Binding of WT1 to in which stable expression of a tetracycline-repressible
conserved elements within the Podocalyxin gene promoter allows tightly regulated inducible expression of
promoter results in potent transcriptional activation, the different WT1 isoforms. WT1 is encoded by distinct
and the specific expression pattern of Podocalyxin alternatively spliced transcripts, of which the most signifi-
in the developing kidney mirrors that of WT1 itself. cant is the variable insertion of three amino acids, lysine,
These observations support a role for WT1 in the threonine, and serine, or “KTS”, between zinc fingers
specific activation of a glomerular differentiation three and four [6]. WT1(KTS) binds to a defined DNA
program in renal precursors and provide a consensus sequence and mediates transactivation of re-
molecular basis for the glomerulonephropathy that sponsive promoters, while WT1(KTS) fails to bind this
is characteristic of Denys-Drash Syndrome. sequence and has been implicated in some aspect of RNA
processing [7]. The presence or absence of 17 amino acids
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We first tested a number of previously reported candidate
target genes to determine whether their expression wasCurrent Biology 2001, 11:1805–1809
modulated by inducible WT1(KTS). We confirmed the
0960-9822/01/$ – see front matter induction of Amphiregulin by WT1(KTS) in RSTEM
 2001 Elsevier Science Ltd. All rights reserved. cells [8]. By inducing one isoform (/ exon 5) of
WT1(KTS) and then examining the electrophoretically
distinct endogenous isoform (/– exon 5), we did not
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Figure 1
Inducible expression of WT1 splice variants in
RSTEM cells. (a) Expression of endogenous
WT1. Western blot analysis of RSTEM cells
cultured at 32C and following a temperature
shift to 39C. (b) The absence of endogenous
WT1 autoregulation following ectopic
tetracycline-regulated expression of WT1
isoforms. Western blot analysis of RSTEM
cells cultured at 32C in tetracycline (tet ;
no expression) or 18 hr following tetracycline
withdrawal (tet ) to induce distinct WT1
isoforms: (/), lacking exon 5 and KTS
splice insertions; (/), encoding exon 5 but
lacking KTS; (/), encoding both exon 5
and KTS. (c) Induction of PC mRNA by
WT1(KTS) in RSTEM cells. Northern blot
analysis of RSTEM cells (39C) with regulated
expression of WT1(KTS) at sequential
times following the withdrawal of tetracycline.
Blots were hybridized for PC, WT1, and
GAPDH (loading control). (d) Induction of PC
protein by WT1(KTS). Western blot
analysis of RSTEM cells (39C) at sequential
intervals following tetracycline withdrawal
and WT1(KTS) induction. (e) Reversibility
of PC induction in RSTEM cells. Northern
blot analysis of cells at sequential intervals
following the readdition of tetracycline and
the suppression of ectopic WT1(KTS)
expression. (f) Induction of PC by
WT1(KTS) in heterologous cell type.
Northern blot analysis of U2OS
osteosarcoma cells with tetracycline-
regulated WT1(KTS) after the withdrawal
of tetracycline for the indicated times. In the
last lane, tetracycline was removed for 24 hr
and then added back for another 24 hr.
confirm the previously postulated autoregulation of WT1 thought to contribute to the formation of slit diaphragms
via the separation of podocyte “foot processes”, therebyexpression (Figure 1b) [9].Wewere also unable to confirm
changes in the expression of a number of other previously allowing filtration of blood through the glomerulus [11,
12]. PC expression was measured by Northern and West-proposed WT1 targets, including EGR1, IGF2, PDGF-A,
Bcl2, IGFR, c-myc, and EGFR (data not shown; [4]). In ern blot analysis. Rapid and dramatic upregulation of PC
was observed following the induction of WT1(KTS),addition, we tested for the WT1 regulation of genes that
play important roles in early kidney development, some with downregulation of expression upon the readdition
of tetracycline (Figure 1c–e). Inducible expression of theof which have been postulated to interact with WT1,
including the transcription factors Pax2 and Pax8 and the transcriptionally inactive WT1(KTS) isoform had no
effect on PC expression (data not shown). In contrast tosecreted factors BMP7, GDNF, and Wnt4. Endogenous
expression of these genes was not altered following the PC, other genes expressed in podocytes, including Podo-
planin, 5-1-6, Synaptopodin, Nephrin, Podocin, -actinin-4,induction of WT1(KTS) in these kidney precursor-
derived cells (data not shown), suggesting that their physi- CD2AP, and Desmin, were not induced by WT1 (data
not shown). The induction of endogenous PC followingological expression in the renal mesenchyme is unlikely
to be directly regulated by WT1. inducible expression of WT1 was not restricted to
RSTEM cells but was also observed in heterologous cell
types, including the U2OS osteosarcoma cell line (FigureDuring kidney development, WT1 expression peaks
1f). In both RSTEM andU2OS cells, the rapid and revers-within glomerular podocyte precursors [10]. This, along
ible induction of PC by WT1(KTS) suggests a directwith the glomerular defects found in Denys-Drash (DDS)
transcriptional mechanism, rather than an indirect conse-patients, prompted us to examine podocyte markers in
quence of a complex cellular differentiation pathway.RSTEM cells following inducible expression of WT1.
The best-characterized marker is Podocalyxin (PC), a
highly specialized transmembrane sialoprotein that is To study the regulatory sequences present within the PC
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Figure 2
Identification of a WT1-responsive element
within the PC promoter. (a) A schematic
representation of the PC promoter (GenBank
accession number AF395890), denoting the
positions of potential WT1 binding sites: the
nested WTE sites PCp1 (1213 to –1227),
the single WTE site PCp2 (495 to –504),
and the GC-rich sequence PCp3 (57 to
–83), indicated by black boxes. All reporter
constructs shown (A–F) were generated in
the promoterless luciferase vector, pGL3.
Fragments I–V indicate regions used for
EMSA. (b) EMSA analysis of the five PC
promoter fragments (I–V), following
incubation with the zinc finger domain of either
WT1(KTS) (lane 2), WT1(KTS) (lane 3),
or probe alone (lane 1). End-labeled probes
were incubated with 500 ng of the respective
GST fusion proteins. Migration positions are
shown for unbound probes of various sizes
(bracket); multiple shifted bands seen with
probes I and V (arrowheads) may represent
the ability of 1 molecule of WT1 to bind to
each fragment. (c) Activation of the PC
promoter by WT1(KTS). Luciferase activity,
relative to vector-transfected cells, was
measured in NIH3T3 cells following
cotransfection of 1 g WT1 ( or KTS)
and the indicated PC reporter constructs (0.2
g). Standard deviations were derived from
three independent experiments. Results were
standardized for transfection efficiency using
a cotransfected reporter (Renilla luciferase).
Equal amounts of DNA were present in each
transfection.
gene promoter, we identified a human bacterial artificial tides 495 to –504: 5-AGGTGGGAGA-3 in the sense
strand), containing a single WTE element, and PCp3chromosome (BAC) spanning the 5 untranslated region
of the transcript. Insertion of 1.6 kb of sequence upstream (nucleotides 57 to –83: 5-GCGGGGGCGGGGGCGG
GGGCGGGGGCC-3 in the sense strand), containingof the transcriptional start site of PC into the promoterless
luciferase reporter plasmid, pGL3, consistently led to four overlapping EGR1 sites, which comprise a GC-rich
motif also recognized by WT1(KTS) [14]. However,3-fold transcriptional activation following transient trans-
fection of WT1(KTS) into NIH3T3 cells, a recipient while EMSA analysis demonstrated binding of bacterially
synthesized WT1 zinc fingers to all three potentialcell line that does not express endogenous WT1 (Figure
2c). The transcriptionally inactive WT1(KTS) had no binding sites (Figure 2b), deletion of either PCp2 or
PCp3 had a minimal effect on transactivation of the PCeffect. We used a combination of nested deletion con-
structs and electrophoretic mobility shift assays (EMSA) promoter reporter, and neither sequence demonstrated
WT1(KTS)-mediated transactivation when introducedto map the WT1(KTS)-responsive domain (Figure 2a).
Deletion of nucleotides 1196 to –1650 abrogated WT1- into a minimal reporter construct (Figure 2c and data not
shown). Taken together, these experiments suggest thatmediated transcriptional activation of the reporter (Figure
2c). This sequence contains a potential binding site, PCp1 the two overlapping WTE elements that constitute PCp1
are primarily responsible for the activation of the PC pro-(nucleotides –1213 to 1227: 5-GGTGGGAGTGGG
TGT-3 in the antisense strand), which contains two moter by WT1(KTS).
overlapping WTE elements, high-affinity WT1(KTS)
binding sites that were identified by PCR-selection exper- Both WT1 and PC have specific expression patterns
within the developing nephron [10, 15]. To compare theiriments and are present in the WT1-responsive Amphire-
gulin promoter [8, 13]. Transfection of a minimal reporter developmental time course of expression, we analyzed
adjacent sections of fetal kidney representing the succes-containing a single copy of PCp1 resulted in 20- to 30-
fold transcriptional activation following the coexpression sive stages of renal differentiation from the initial con-
densing subcortical mesenchyme to the mature tubulesof WT1(KTS) (Figure 2c). We identified two other
potential binding sites in the PC promoter: PCp2 (nucleo- and glomeruli (Figure 3a). Consistentwith previous obser-
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Figure 3
Colocalization of WT1 and PC in the
developing kidney. (a) Immunohistochemical
analysis of adjacent sections from 20-week
human kidneys stained with antibodies
against WT1 or PC. Both antibodies faintly
stain early mesenchymal cells within the
blastemal zone (BL). High-level expression of
both WT1 and PC is evident in developing
glomeruli (DG) and mature glomerular (MG)
podocytes (200). Inset: higher
magnification (400) to illustrate WT1 and
PC expression in undifferentiated blastemal
cells (arrowhead) and in podocyte precursors
of an S-shaped body (arrow). (b) High
magnification (400) of glomeruli from normal
and DDS kidneys from a 3-year-old child
stained using hemotoxin and eosin (H&E), anti-
WT1, or anti-PC antibodies. The few
glomeruli that do form in DDS patients are
sclerotic and have decreased staining for
both WT1 and PC.
vations, low levels of nuclear WT1 are first detectable by the developing kidney, PC andWT1 are also coexpressed
in mesothelium and hematopoietic precursors [10, 16–18].immunohistochemistry within the induced and unin-
duced metanephric mesenchyme. As patterning of the
nephron proceeds, WT1 expression peaks and becomes The renal parenchyma of patients withDDS shows exten-
sive glomerulosclerosis, nephritis, and effacement and fu-restricted to the presumptive glomerular visceral epithe-
lial cells of developing glomeruli. WT1 expression is sion of podocyte foot processes [3]. Immunohistochemis-
try demonstrates reduced numbers of glomerular cellsmaintained as these cells develop into mature podocytes.
Expression of PC follows that of WT1, with expression with reactivity for WT1 and PC (Figure 3b). The possibil-
ity that a reduction in PC expression accompanying thefirst evident in the condensed blastema and podocyte
precursors. Expression levels peak and are maintained in constitutional WT1 defect in DDS may contribute to
the glomerular abnormalities that define this syndrome isthe developing and mature glomerular podocytes. The
superimposition of temporal and spatial WT1 and PC supported by a number of observations. In vivo treatments
that disrupt the negatively charged extracellular domainexpression patterns supports a physiological interaction.
In addition to colocalization within specific structures of of PC lead to the effacement of foot processes and renal
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11. Kerjaschki D, Sharkey DJ, Farquhar MG: Identification andfailure [19], and ectopic expression of PC in cultured
characterization of podocalyxin—the major sialoprotein of
kidney cells suppresses intercellular aggregation, consis- the renal glomerular epithelial cell. J Cell Biol 1984, 98:1591-
1596.tent with an antiadhesion role for this protein [20]. While
12. Kershaw DB, Beck SG, Wharram BL, Wiggins JE, Goyal M, Thomasthis manuscript was under review, Doyonnas et al. re- PE, et al.: Molecular cloning and characterization of human
ported the inactivation of PC in mice by homologous podocalyxin-like protein. J Biol Chem 1997, 272:15708-15714.
13. Nakagama H, Heinrich G, Pelletier J, Housman DE: Sequence andrecombination [16]. Pc null mice die within 24 hr of birth
structural requirements for high-affinity DNA binding by the
of anuric renal failure attributed to the persistent intercel- WT1 gene product. Mol Cell Biol 1995, 15:1489-1498.
14. Rauscher FJ, Morris JF, Tournay OE, Cook DM, Curran T: Bindinglular association of podocytes via tight junctions and their
of the Wilms’ tumor locus zinc finger protein to the EGR-1failure to form foot processes and slit diaphragms. consensus sequence. Science 1990, 250:1259-1262.
15. Schnabel E, Dekan G, Miettinen A, Farquhar MG: Biogenesis of
podocalyxin—the major glomerular sialoglycoprotein—in theThe identification of PC as a physiological target gene of
newborn rat kidney. Eur J Cell Biol 1989, 48:313-326.WT1 points to a direct role for WT1 in the activation of 16. Doyonnas R, Kershaw D, Duhme C, Merkens H, Chelliah S, Graf T,
et al.: Anuria, omphalocele, and perinatal lethality in micea terminal differentiation program in glomerular podo-
lacking the CD34-related protein podocalyxin. J Exp Med 2001,cytes, a stage of kidney development that is not attained in
194:13-27.
wt1 null mice. The apparent role ofWT1 in differentiating 17. Hara T, Nakano Y, Tanaka M, Tamura K, Sekiguchi T, Minehata K, et
al.: Identification of podocalyxin-like protein 1 as a novelglomeruli is consistent with the recent observation that
cell surface marker for hemangioblasts in the murine aorta-WT1 directly induces lineage-specific hematopoietic dif- gonad-mesonephros region. Immunity 1999, 11:567-578.
18. Ellisen L, Carlesso N, Cheng T, Scadden D, Haber D: The Wilmsferentiation [18]. While these properties are most clearly
tumor suppressor WT1 directs stage-specific quiescencedefined for the transcriptionally active WT1(KTS) iso-
and differentiation of human hematopoietic progenitor cells.
form, the contribution of WT1(KTS) remains poorly EMBO J 2001, 20:1897-1909.
19. Kerjaschki D: Dysfunctions of cell biological mechanisms ofunderstood. Patients with Frasier syndrome and recently
visceral epithelial cell (podocytes) in glomerular diseases.generated mouse models, both of which display selective Kidney Int 1994, 45:300-313.
reductions in WT1(KTS) expression, also demonstrate 20. Takeda T, Go W, Orlando R, Farquhar M: Expression of
podocalyxin inhibits cell-cell adhesion and modifies junctionalglomerular abnormalities [21, 22]. Identifying down-
properties in Madin-Darby canine kidney cells. Mol Biol Cell
stream effectors of WT1(KTS) will be essential to un- 2000, 11:3219-3232.
21. Barbaux S, Niaudet P, Gubler M-C, Grunfeld J-P, Jaubert F, Kuttennderstanding its contribution to kidney differentiation.
F, et al.: Donor splice-site mutations in WT1 are responsible
for Frasier syndrome. Nat Genet 1997, 17:467-470.
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